Analysis also includes guidelines against treatment with azithromycin, ivermectin and other drugs that have not been proven effective; indication is focused on hospitalized patients
A technical group formed to advise the Ministry of Health prepared a preliminary document with guidelines against the use of chloroquine, azithromycin, ivermectina and other drugs without proven efficacy in the treatment of Covid-19 in hospitalized patients. The analysis is part of the development of a single protocol with guidelines to assist health professionals, especially those who worked in other areas and were called to the front line. In the text, experts say that “some drugs have been tested and have not shown clinical benefits in the population of hospitalized patients, and should not be used”. The group’s coordinator, pulmonologist Carlos Carvalho, Carlos Carvalho reinforces that the document focuses on hospitalized patients and does not include indications for the early use of these drugs. “When we finalize this hospitalized patient protocol, it may be that the ministry asks us to continue and discuss this pharmacological treatment in the pre-hospital environment. But that was not the subject of our study. ”
The document has already received a favorable opinion from the National Commission for the Incorporation of Technologies in the Unified Health System. The work was submitted to public consultation and may receive contributions for ten days. According to pulmonologist Carlos Carvalho, the text also provides guidance on mechanical ventilation, use of oxygen and medications for the “intubation kit“. “Setting goals for oxygenation, do not let it be below a certain value, because that would bring risk to the patient, and do not leave it above another value, because it would be a waste of oxygen. The same thing when the patient needs to be intubated, what would be the first line, second line and third line drugs so that the colleague has guidance on which are the best drugs and how to use them in order to make a quick and safe intubation ”, he said. After the public consultation, a new evaluation will be carried out by Conitec, which will forward a report with recommendations to the Ministry of Health.
* With information from the reporter Leticia Santini